Onconova Therapeutics
ONTX
#9639
Rank
โ‚ฌ19.93 M
Marketcap
0,95ย โ‚ฌ
Share price
-0.47%
Change (1 day)
-6.43%
Change (1 year)

Revenue for Onconova Therapeutics (ONTX)

Revenue in 2024 (TTM): โ‚ฌ0.2 Million

According to Onconova Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.21 Million. In 2023 the company made a revenue of โ‚ฌ0.2 Million a decrease over the revenue in the year 2022 that were of โ‚ฌ0.21 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Onconova Therapeutics from 2012 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ0.2 M2.13%
2023 โ‚ฌ0.2 M-2.97%
2022 โ‚ฌ0.21 M5.58%
2021 โ‚ฌ0.19 M6.26%
2020 โ‚ฌ0.18 M-90.36%
2019 โ‚ฌ1.94 M81.54%
2018 โ‚ฌ1.07 M63.65%
2017 โ‚ฌ0.65 M-87.56%
2016 โ‚ฌ5.27 M-49.68%
2015 โ‚ฌ10.47 M1492.84%
2014 โ‚ฌ0.65 M-80.89%
2013 โ‚ฌ3.44 M-90.14%
2012 โ‚ฌ34.91 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ24.53 M 11,284.51%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.04 B 487,166.37%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ14.29 B 6,635,740.71%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ72.23 M 33,426.11%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.6 M 179.58%๐Ÿ‡บ๐Ÿ‡ธ USA